Polyphenols have been demonstrated to ameliorate several risk markers of type 2 diabetes and its complications, such as improvement of insulin sensitivity, inhibition of α-amylase and α-glucosidase, reduction of inflammatory cytokines, prevention of dyslipidemia, oxidative stress reduction, and enhancement of endothelial function. This evidence concerns the gene INS and metabolic syndrome.